Trivitron, BioSystems, Spain to set up facility in Chennai

CHENNAI: Medical technology company Trivitron has forged an alliance with BioSystems of Spain to manufacture IVD Reagents. Through this tie-up,

BioSystems will manufacture IVD reagents for diagnostic lab use by setting up its manufacturing facility at Trivitron's Medical Technology Park (MTP) in Chennai. An investment of Rs 40 to Rs 50 crore is envisaged in the first phase at the facility. "This facility will cater to both domestic and foreign market. Products are expected to be rolled out by mid-2010. The MTP is coming up on a 23-acre land at Sriperumbudur, near Chennai, on which Trivitron has already invested Rs 170 crore," Trivitron MD G S K Velu said. The plant will be set up with the help of a specialist technical expert from Spain and will operate according to the good manufacturing practices (GMP), the ISO 9001, the ISO 13485 and the European Union laws on ‘In Vitro’ diagnostics products. BioSystems MD Antonio Elduque said it decided to expand its operations by setting up a facility in India through a JV as it has considered India an emerging preferred healthcare destination having infrastructure and technology matching that of the UK, Europe and USA. "We have identified Trivitron for the tie up as it is creating the first-of-its-kind, world class medical technology park ( MTP) in Chennai. This will be the first facility outside Spain, for the manufacture of clinical chemistry products. Production is expected to commence during 2010," he said in a release here on Wednesday. BioSystems is among the largest manufacturers of clinical chemistry reagents and instruments in Europe and the alliance will benefit from its three decades of research, advancements and expertise in clinical chemistry